fda semaglutide warning november 2025 glp-1 From a new Perspective by Amanda Banks, MD: On February Generic GLP-1 medications: Current and – U.S. FDA finds no evidence

When it comes to achieving brighter, more even-toned skin, two powerful ingredients often stand out Glutathione and Vitamin C

What To Avoid In Creatine Supplements All the creatine supplements in our guide are a safe bet, though others may require a little more research

The FDA cleared orforglipron for chronic weight management in adults with obesity, or overweight with at least one weight-related comorbidity, based on the ATTAIN clinical program which showed placebo-adjusted weight loss of 7.5% to 11.2% in non-diabetics (ATTAIN-1) and 5.1% to 9.6% in diabetics at different doses, along with the expected glycaemic benefits (ATTAIN-2)

In vitro differentiation of human umbilical cord whartons jelly mesenchymal stromal cells to insulin producing clusters

Mild cramping, early fullness or post-meal discomfort is expected early on in treatment or after dose increases and tends to improve with time